Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
Anticancer Research
|
February 13, 2010
Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors
Thehang Luu, Warren Chow, Dean Lim, et al.
Frontiers in Immunology
|
December 5, 2018
Effective Targeting of TAG72<sup>+</sup> Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells
John P Murad, Anna K Kozlowska, Hee Jun Lee, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
October 29, 2020
A nurse-led intervention for fear of cancer progression in advanced cancer: A pilot feasibility study
Anne M Reb, Tami Borneman, Denice Economou, et al.
Cancer Chemotherapy and Pharmacology
|
September 16, 2019
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial
Thehang Luu, Paul Frankel, Jan H Beumer, et al.
Gynecologic Oncology
|
November 19, 2021
Characterizing impact of positive lymph node number in endometrial cancer using machine-learning: A better prognostic indicator than FIGO staging?
Colton Ladbury, Richard Li, Jay Shiao, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
A Real-Life Reproducibility Assessment for NMR Metabolomics
Cristina Stavarache, Alina Nicolescu, Cătălin Duduianu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
January 8, 2020
Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies
David Akhavan, Paul Yazaki, Dave Yamauchi, et al.
The Oncologist
|
August 6, 2021
Recall of Genomic Testing Results Among Patients with Cancer
Sam E Wing, Hengrui Hu, Lisa Lopez, et al.
Molecules (Basel, Switzerland)
|
November 18, 2020
Monitoring Methylmalonic Aciduria by NMR Urinomics
Alina Nicolescu, Daniela Blanita, Chiril Boiciuc, et al.
Journal for Immunotherapy of Cancer
|
April 5, 2024
Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer
Antons Martincuks, Chunyan Zhang, Theresa Austria, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
Anticancer Research
|
February 13, 2010
Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors
Thehang Luu, Warren Chow, Dean Lim, et al.
Frontiers in Immunology
|
December 5, 2018
Effective Targeting of TAG72<sup>+</sup> Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells
John P Murad, Anna K Kozlowska, Hee Jun Lee, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
October 29, 2020
A nurse-led intervention for fear of cancer progression in advanced cancer: A pilot feasibility study
Anne M Reb, Tami Borneman, Denice Economou, et al.
Cancer Chemotherapy and Pharmacology
|
September 16, 2019
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial
Thehang Luu, Paul Frankel, Jan H Beumer, et al.
Gynecologic Oncology
|
November 19, 2021
Characterizing impact of positive lymph node number in endometrial cancer using machine-learning: A better prognostic indicator than FIGO staging?
Colton Ladbury, Richard Li, Jay Shiao, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
A Real-Life Reproducibility Assessment for NMR Metabolomics
Cristina Stavarache, Alina Nicolescu, Cătălin Duduianu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
January 8, 2020
Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies
David Akhavan, Paul Yazaki, Dave Yamauchi, et al.
The Oncologist
|
August 6, 2021
Recall of Genomic Testing Results Among Patients with Cancer
Sam E Wing, Hengrui Hu, Lisa Lopez, et al.
Molecules (Basel, Switzerland)
|
November 18, 2020
Monitoring Methylmalonic Aciduria by NMR Urinomics
Alina Nicolescu, Daniela Blanita, Chiril Boiciuc, et al.
Journal for Immunotherapy of Cancer
|
April 5, 2024
Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer
Antons Martincuks, Chunyan Zhang, Theresa Austria, et al.
Page
of 6